CAS: 1001908-89-9 - SRT2183
![(R)-N-(2-(3-((3-hydroxypyrrolidin-1-yl)Methyl)iMidazo[2,1-b]thiazol-6-yl)phenyl)-2-naphthaMide](https://static.cymitquimica.com/products/IN/thumb/DA0092WD.jpg)
(R)-N-(2-(3-((3-hydroxypyrrolidin-1-yl)Methyl)iMidazo[2,1-b]thiazol-6-yl)phenyl)-2-naphthaMide
CAS:1001908-89-9
Formula:
C27H24N4O2S
Purity:
99%
Molecular weight:
468.5701
Ref: IN-DA0092WD
| 1mg | 79.00 € | ||
| 5mg | 116.00 € | ||
| 10mg | 142.00 € | ||
| 25mg | 154.00 € | ||
| 50mg | 259.00 € | ||
| 100mg | 586.00 € |
Estimated delivery in United States, on Tuesday 10 Dec 2024
SRT 2183
CAS:1001908-89-9
SRT 2183 is a selective activator of Sirtuin-1 (SIRT1, EC1.5 : 0.36 μM).
Formula:
C27H24N4O2S
Purity:
97.86%
Color and Shape:
Solid
Molecular weight:
468.57
Ref: TM-T16932
| 1mg | 50.00 € | ||
| 2mg | 71.00 € | ||
| 5mg | 106.00 € | ||
| 10mg | 162.00 € | ||
| 25mg | 276.00 € | ||
| 50mg | 423.00 € | ||
| 100mg | 609.00 € | ||
| 1mL*10mM (DMSO) | 111.00 € |
Estimated delivery in United States, on Tuesday 17 Dec 2024
SRT 2183
CAS:1001908-89-9
SRT 2183 is an experimental drug that has been shown to have anti-cancer properties. It …
Formula:
C27H24N4O2S
Purity:
Min. 95%
Molecular weight:
468.57 g/mol
Ref: 3D-BQB90889
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 21 Jan 2025
